Keywords: mevacor, approved, primary, prevention, merck, co, hmg-coa

Mevacor approved for primary prevention

Article | 18 March 1999

Print This

Merck & Co's HMG-CoA reductase inhibitor Mevacor (lovastatin) has beenapproved in the USA for a new indication, to reduce the risk ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in